Travere Therapeutics, Inc.TVTXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P86
Within normal range
vs 2Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202586.27%
2024-172.00%
202365.68%
2022-45.18%
202115.45%
2020-2.89%
2019-36.22%
2018-64.94%
2017-19.38%
2016-136.96%